# FDA 483 - Rentschler Biopharma SE - February 15, 2022

Source: https://www.globalkeysolutions.net/records/483/rentschler-biopharma-se/dd46571c-c83f-449f-a4c7-b1b10e214eae

> FDA 483 for Rentschler Biopharma SE on February 15, 2022. Product: N/A. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Rentschler Biopharma SE
- Inspection Date: 2022-02-15
- Office Name: Division of Biotechnology Manufacturing

## Related Documents

- [EIR - 2022-02-15](https://www.globalkeysolutions.net/records/eir/rentschler-biopharma-se/d3900ca0-3215-45e5-b136-19fb4ba548b9)
- [483 - 2023-03-07](https://www.globalkeysolutions.net/records/483/rentschler-biopharma-se/a356438e-6da6-487c-a025-d6d0b1b6c608)
- [483 - 2022-02-15](https://www.globalkeysolutions.net/records/483/rentschler-biopharma-se/dea4278a-24e6-4a98-9c7d-044c5991701d)
- [483 - 2023-03-07](https://www.globalkeysolutions.net/records/483/rentschler-biopharma-se/fc27ece6-9564-41bd-beb7-3d1aa9dcc656)
- [483 - 2022-02-15](https://www.globalkeysolutions.net/records/483/rentschler-biopharma-se/93d07408-e6d3-4358-bb3c-2acbf0b6f12a)

Company: https://www.globalkeysolutions.net/companies/rentschler-biopharma-se/da50fa41-24f6-449f-bf90-45eccb97d9ba

Office: https://www.globalkeysolutions.net/offices/division-of-biotechnology-manufacturing/3e3018f1-aa48-4010-a554-96f557f17c55